Institutional Ownership
Jade Biosciences Inc
CUSIP 008064206COM NEWJBIOQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
115
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest Mar 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 5, 2026 | Sofinnova Venture Partners X, L.P. ("Svp X") | 13D/A | 0.3% | — | SEC |
| 2 | Feb 17, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 5.12M | SEC |
| 3 | Feb 17, 2026 | Janus Henderson Group PLC | 13G | 6.2% | 3.06M | SEC |
| 4 | Feb 17, 2026 | Bellevue Group AG | 13G | 6.8% | 3.34M | SEC |
| 5 | Feb 13, 2026 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 6 | Jan 30, 2026 | The Vanguard Group | 13G/A | 4.2% | 2.10M | SEC |
| 7 | Nov 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 4.2% | 1.38M | SEC |
| 8 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 7.0% | 2.28M | SEC |
| 9 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 6.6% | 2.15M | SEC |
| 10 | Oct 16, 2025 | Ra Capital Management, L.P. | 13G | 7.0% | 3.21M | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Jade Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 7.09M | $99.55M |
| 2 | Fairmount Funds Management LLC | 4.55M | $63.98M |
| 3 | Ra Capital Management, L.P. | 3.67M | $51.58M |
| 4 | Bellevue Group AG | 3.50M | $49.20M |
| 5 | Venrock Adviser, LLC | 3.22M | $45.25M |
| 6 | Janus Henderson Group PLC | 3.11M | $43.56M |
| 7 | Blackrock, Inc. | 2.31M | $32.51M |
| 8 | Baker Bros. Advisors LP | 1.64M | $23.06M |
| 9 | Remedium Capital Partners, LLC | 1.58M | $22.17M |
| 10 | Versant Venture Management, LLC | 1.53M | $21.44M |